Imaging of Non–Small Cell Lung Cancer of the Superior Sulcus

References

• 1 American Joint Commission on Cancer. In: Greene FL, Page DL, Fleming ID, et al, eds. American Joint Commission on Cancer cancer staging manual. 6th ed. New York, NY: Springer-Verlag, 2002; 301–346.
  Google Scholar
• 2 BilskyMH, Vitaz TW, Boland PJ, Bains MS, Rajaraman V, Rusch VW. Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. J Neurosurg2002; 97(3 suppl): 301–309.
  MedlineGoogle Scholar
• 3 DartevelleP, Macchiarini P. Surgical management of superior sulcus tumors. Oncologist1999; 4(5): 398–407.
  MedlineGoogle Scholar
• 4 GandhiS, Walsh GL, Komaki R, et al. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg1999; 68(5): 1778–1784; discussion 1784–1785.
  MedlineGoogle Scholar
• 5 AndersonTM, Moy PM, Holmes EC. Factors affecting survival in superior sulcus tumors. J Clin Oncol1986; 4(11): 1598–1603.
  MedlineGoogle Scholar
• 6 KomakiR, Roth JA, Walsh GL, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys2000; 48(2): 347–354.
  MedlineGoogle Scholar
• 7 RuschVW, Parekh KR, Leon L, et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg2000; 119(6): 1147–1153.
  MedlineGoogle Scholar
• 8 PaulsonD. Technical considerations in stage III disease: the “superior sulcus” lesion. In: Delarue N, Eschapasse H, eds. International trends in general thoracic surgery. Philadelphia, Pa: Saunders, 1985; 121–133.
  Google Scholar
• 9 GinsbergRJ, Martini N, Zaman M, et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg1994; 57(6): 1440–1445.
  MedlineGoogle Scholar
• 10 VallieresE, Karmy-Jones R, Mulligan MS, Wood DE. Pancoast tumors. Curr Probl Surg2001; 38(5): 293–376.
  MedlineGoogle Scholar
• 11 HilarisBS, Martini N, Wong GY, Nori D. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am1987; 67(5): 965–977.
  MedlineGoogle Scholar
• 12 DwamenaBA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology1999; 213(2): 530–536.
  Google Scholar
• 13 VansteenkisteJF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol1998; 16(6): 2142–2149.
  MedlineGoogle Scholar
• 14 DartevellePG. Herbert Sloan Lecture. Extended operations for the treatment of lung cancer. Ann Thorac Surg1997; 63(1): 12–19.
  MedlineGoogle Scholar
• 15 YorkJE, Walsh GL, Lang FF, et al. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg1999; 91(1 suppl): 74–80.
  MedlineGoogle Scholar
• 16 TakasugiJE, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imaging1989; 4(1): 41–48.
  MedlineGoogle Scholar
• 17 BealeR, Slater R, Hennington M, Keagy B. Pancoast tumor: use of MRI for tumor staging. South Med J1992; 85(12): 1260–1263.
  MedlineGoogle Scholar
• 18 HeelanRT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology1989; 170(3 pt 1): 637–641.
  Google Scholar
• 19 RapoportS, Blair DN, McCarthy SM, Desser TS, Hammers LW, Sostman HD. Brachial plexus: correlation of MR imaging with CT and pathologic findings. Radiology1988; 167(1): 161–165.
  Google Scholar
• 20 IezziA, Magarelli N, Carriero A, Podda PF, Ciccotosto C, Bonomo L. Staging of pulmonary apex tumors. Computerized tomography versus magnetic resonance [in Italian]. Radiol Med (Torino)1994; 88(1–2): 24–30.
  MedlineGoogle Scholar
• 21 DemondionX, Boutry N, Drizenko A, Paul C, Francke JP, Cotten A. Thoracic outlet: anatomic correlation with MR imaging. AJR Am J Roentgenol2000; 175(2): 417–422.
  MedlineGoogle Scholar
• 22 KalffV, Hicks RJ, MacManus MP, et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol2001; 19(1): 111–118.
  MedlineGoogle Scholar
• 23 PatzEF Jr, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest1995; 108(6): 1617–1621.
  MedlineGoogle Scholar
• 24 SteinertHC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology1997; 202(2): 441–446.
  Google Scholar
• 25 VineyRC, Boyer MJ, King MT, et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol2004; 22(12): 2357–2362.
  MedlineGoogle Scholar
• 26 van TinterenH, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet2002; 359(9315): 1388–1393.
  MedlineGoogle Scholar
• 27 RuschVW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg2001; 121(3): 472–483.
  MedlineGoogle Scholar
• 28 RuschVW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol2007; 25(3): 313–318.
  MedlineGoogle Scholar